Nikolai Graf von Keyserlingk

Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24)

Petra Heffeter, Michael A. Jakupec, Wilfried Körner et al. · Biochemical Pharmacology · 2005 · 137 citations

Natural Sciences, Chemistry, Oncology +10

Early results from a phase I study on orally administered tris(8-quinolinolato)gallium(III) (FFC11, KP46) in patients with solid tumors ? a CESAR study (Central European Society for Anticancer Drug Research ? EW

Ralf‐Dieter Hofheinz, C. Dittrich, Michael A. Jakupec et al. · International Journal of Clinical Pharmacology and Therapeutics · 2005 · 63 citations

Medicine, Oncology, Pharmacology +10

Synthesis and structure-activity relationships of mono- and dialkyl-substituted oxaliplatin derivatives

Ladislav Habala, M. Galanski, Afshin Yasemi et al. · European Journal of Medicinal Chemistry · 2005 · 46 citations

Pharmacy, Chemistry, Medicinal Chemistry +11

The First Metal-Based Paullone Derivative with High Antiproliferative Activity in Vitro

Anatoly A. Dobrov, Vladimir B. Arion, N. Kandler et al. · Inorganic Chemistry · 2006 · 43 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Synthesis, crystal structure and pH dependent cytotoxicity of (SP-4-2)-bis(2-aminoethanolato-κ2N,O)platinum(II) – a representative of novel pH sensitive anticancer platinum complexes

M. Galanski, Christian Baumgärtner, Kristof Meelich et al. · Inorganica Chimica Acta · 2004 · 42 citations

Natural Sciences, Chemistry, Medicinal Chemistry +12